GeneLink Inc. announced earnings results for the first quarter ended March 31, 2012. For the quarter, the company reported net sales were $771,664, including GeneWize retail revenues through February 10, 2012. The net loss was $105,673, which included a book gain of $759,054 from the sale of GeneWize. The net operating loss was $788,468. Net cash used in operating activities was $464,468.